Saturday 17 October 2026
Export HCAT’s income statement to Excel — free account
Health Catalyst, Inc.
HCAT Healthcare Health Information Services
Health Catalyst, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $311.1 million, up 1.48% from fiscal 2024. In the quarter to June 2026, revenue fell 12.7%, EPS grew 6.78%, free cash flow grew 64.3% and total debt was flat, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.
1.73
0.07
−3.89%
Follow HCAT
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
5 | 5 | 5 | 4 |
+8 more TTM periods Free account |
| (118.12%) | (103.02%) | (58.26%) | (31.33%) | ||
| (54.33%) | (40.69%) | (26.14%) | (15.37%) | ||
ROIC |
(102.14%) | (84.56%) | (33.15%) | (14.66%) | |
Return on Tangible Assets |
(139.42%) | (241.95%) | (156.71%) | (97.78%) | |
Average Days of Receivables |
52.33 | 71.37 | 69.36 | 69.42 | |
Free Cash Flow per Share |
0.09 | (0.04) | (0.30) | (0.48) | |
Free Cash Flow |
6.59 | (2.71) | (20.78) | (33.46) | |
Capital Expenditures |
(21.65) | (21.68) | (21.51) | (20.76) | |
| Other line items | |||||
Cash ROIC |
1.84% | (0.68%) | (4.20%) | (5.80%) | |
Accounts Receivable Turnover |
5.30 | 4.91 | 5.35 | 5.66 | |
Accounts Payable Turnover |
16.75 | 14.69 | 15.34 | 17.59 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
21.03 | 28.16 | 21.43 | 10.67 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.01 | |
Research and Development Expense of Revenue |
14.71% | 14.67% | 16.00% | 17.36% | |
Selling, General and Administrative Expense of Revenue |
33.70% | 32.29% | 32.79% | 34.09% | |
Share Based Compensation of Revenue |
6.03% | 7.68% | 8.68% | 10.67% | |
Interest Coverage |
(14.40) | (14.38) | (9.81) | (6.41) | |
Operating CF/Net income |
(0.11) | (0.07) | 0.00 | 0.12 | |
Depreciation/Fixed assets |
7.63 | 7.42 | 4.86 | 2.48 | |
Capex/Depreciation |
(0.08) | (0.08) | (0.13) | (0.26) | |
Revenue per Share |
3.95 | 4.17 | 4.45 | 4.49 | |
Operating CF per Share |
0.38 | 0.26 | 0.01 | (0.18) | |
Capex per Share |
(0.29) | (0.30) | (0.31) | (0.29) | |
Capex to Sales |
0.07 | 0.07 | 0.07 | 0.07 |
Columns are period end dates